The FDA has not displayed sufficient urgency throughout the COVID-19 crisis—and is threatening to repeat its mistakes with the ongoing outbreak of monkeypox. It’s long past time for lawmakers to reform the sclerotic agency.
It’s Time To Cure The FDA’s Regulatory Sclerosis
